N/A
N=96
Contraception and Pregnancy in Diabetes Mellitus
Diabetes Mellitus, Type 1 · Contraception
Bottom Line
View on ClinicalTrials.gov: NCT04523454 ↗Enrolled (actual)
96
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: Number of Women 'Prepared for Pregnancy\ — 3 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Imperial College London
- Primary completion
- Aug 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Women 'Prepared for Pregnancy\ |
3 | — |
| SECONDARY Number of Women Aware of the Importance of Good Glycaemic Control Prior to Pregnancy |
69 | — |
| SECONDARY Number of Women Who Had Attended Pre-conception Counselling |
17 | — |
| SECONDARY Number of Women Aware of Risks to the Foetus in Pregnancy in Women With Diabetes |
89 | — |
| SECONDARY Number of Women Aware of Any Risks to the Mother in Pregnancy With Pre-gestational Diabetes |
80 | — |
Summary
This study seeks to expand upon and update this body of work. It will explore the knowledge and understanding women with diabetes have around pregnancy and conception, as well as establish how well prepared these women are for a pregnancy. Using this data, we will develop better services to inform women with diabetes about the contraception and pregnancy, as well inform the development of pre-conception counselling services for women with diabetes. If successful, we would anticipate seeing an improvement in performance in future National Diabetes in Pregnancy audits.
Eligibility Criteria
Inclusion Criteria
- Women aged 18-50 years (reproductive age) who are not currently pregnant
- Previous diagnosis of Diabetes Mellitus
Exclusion Criteria
- Inability to understand and write in the English language
- Unable to participate due to other factors, as assessed by the Chief Investigators
- A history of gestational diabetes but not diabetes mellitus.
- Pregnant women
Data sourced from ClinicalTrials.gov (NCT04523454). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.